Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Dare Bioscience, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 34 | 37 | +3 |
| Shares | 3.39M | 4.83M | +1.44M (+42.6%) |
| Value | $6.40M | $8.07M | +$1.67M (+26.1%) |
New holders (10)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 181,582 | $303.0K | 0.00% |
| Virtu Financial LLC | 93,485 | $156.0K | 0.01% |
| Citadel Advisors LLC | 66,613 | $111.0K | 0.00% |
| Charles Schwab Investment Management Inc | 30,532 | $51.0K | 0.00% |
| Millennium Management LLC | 27,103 | $45.0K | 0.00% |
| Two Sigma Investments, LP | 12,739 | $21.0K | 0.00% |
| Gsa Capital Partners LLP | 12,046 | $20.0K | 0.00% |
| Victory Capital Management Inc | 10,155 | $17.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 1,400 | $2.00K | 0.00% |
| NVWM, LLC | 520 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Two Sigma Securities, LLC | 44,394 | $84.0K |
| Two Sigma Advisers, LP | 33,000 | $62.0K |
| Citigroup Inc | 8,200 | $15.0K |
| Federation des caisses Desjardins du Quebec | 4,000 | $7.56K |
| Reilly Financial Advisors, LLC | 2,476 | $5.00K |
| Bank of America Corp | 2,320 | $4.00K |
| Royal Bank of Canada | 50 | $0 |